Muscle Protein UNC45B Declines With Age and Drives Sarcopenia
A newly identified chaperone protein drops in aging muscle, triggering weakness before atrophy — and impairing sleep and bone density.
Summary
Scientists have identified UNC45B, a protein that helps assemble myosin in muscle fibers, as a key driver of age-related muscle decline. In aging mice, UNC45B levels dropped significantly by 24 months. When researchers artificially reduced UNC45B in young mice, muscle force fell first, followed by muscle mass loss — mirroring the pattern seen in human sarcopenia. Knockout mice also showed reduced bone mineral density, lower body temperature, and worse sleep quality. Notably, metabolic markers like glucose tolerance and insulin sensitivity were unaffected. The findings suggest UNC45B is essential for maintaining fast-twitch muscle function, and its age-related decline may be a root cause — not just a consequence — of sarcopenia, with ripple effects on bone health and sleep.
Detailed Summary
Sarcopenia — the progressive loss of muscle mass and strength with aging — is one of the most consequential contributors to frailty, falls, and reduced healthspan. A critical but underexplored question is why muscle force declines before visible atrophy occurs. This study points to a compelling molecular answer: the myosin co-chaperone UNC45B.
Researchers examined UNC45B expression in mouse gastrocnemius muscle across the lifespan, finding a marked reduction at 24 months of age. To test causality, they used adeno-associated virus vectors to knock down Unc45b in the triceps surae of young (3-month-old) mice. The result was a sequential deterioration: plantar flexor torque declined first, followed by a reduction in gastrocnemius muscle mass — precisely recapitulating the temporal pattern of human sarcopenia.
Mechanistic experiments using mechanically skinned muscle fibers revealed that maximum calcium-activated force was preserved after Unc45b knockdown, but depolarization-induced force relative to maximum calcium-activated force was reduced. This suggests UNC45B affects excitation-contraction coupling rather than the contractile machinery itself. The protein appears especially critical for fast-twitch fiber integrity.
Using tamoxifen-inducible skeletal muscle-specific knockout mice, the team confirmed whole-body reductions in muscle mass and force. Strikingly, these mice also showed reduced bone mineral density, decreased locomotor activity, lower body temperature during sleep, and impaired non-REM sleep depth — despite normal glucose tolerance and insulin sensitivity. This reveals that muscle-intrinsic UNC45B loss has systemic consequences beyond metabolism.
The study establishes UNC45B as a myofiber-intrinsic promoter of sarcopenia and opens new avenues for therapeutic targeting. Caveats include reliance on mouse models and abstract-only availability limiting full methodological assessment.
Key Findings
- UNC45B protein levels decline significantly in mouse muscle by 24 months, preceding visible atrophy.
- Reducing UNC45B causes muscle force loss before muscle mass loss, mirroring human sarcopenia progression.
- UNC45B loss impairs excitation-contraction coupling in fast-twitch fibers, not peak contractile force.
- Muscle-specific UNC45B knockout reduces bone mineral density and disrupts non-REM sleep depth.
- Metabolic function (glucose tolerance, insulin sensitivity) remains intact despite significant muscle loss.
Methodology
The study used AAV-mediated Unc45b knockdown in young mice and tamoxifen-inducible skeletal muscle-specific knockout (imKO) mice to dissect the role of UNC45B in muscle physiology. Outcomes included torque measurements, mechanically skinned fiber force assays, bone density scans, metabolic testing, and sleep/activity monitoring. Mouse models spanned multiple ages to capture age-related expression changes.
Study Limitations
This summary is based on the abstract only, as the full paper is not open access, limiting assessment of statistical rigor and full methodology. All experiments were conducted in mice, and translation to human sarcopenia requires validation in human muscle tissue and clinical studies. The mechanisms linking UNC45B loss to sleep disruption and bone density changes remain to be fully elucidated.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.